Antibodies towards HDL components in type 2 diabetes patients are associated with modifications in the anti-atherogenic properties of HDL

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S277-S278
JournalDiabetologia
Volume54
Publication statusPublished - Sep 2011

Cite this